433
Views
60
CrossRef citations to date
0
Altmetric
Reviews

Therapeutic potential of novel glutamate receptor antagonists in migraine

&
Pages 789-803 | Published online: 09 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Giorgio Lambru, Anna P. Andreou, Martina Guglielmetti & Paolo Martelletti. (2018) Emerging drugs for migraine treatment: an update. Expert Opinion on Emerging Drugs 23:4, pages 301-318.
Read now
Anna Ferrari, Cecilia Rustichelli & Carlo Baraldi. (2017) Glutamate receptor antagonists with the potential for migraine treatment. Expert Opinion on Investigational Drugs 26:12, pages 1321-1330.
Read now
János Tajti, Anett Csáti & László Vécsei. (2014) Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors. Expert Opinion on Drug Metabolism & Toxicology 10:11, pages 1509-1520.
Read now
Gáspár Oláh, Judit Herédi, Ákos Menyhárt, Zsolt Czinege, Dávid Nagy, János Fuzik, Kitti Kocsis, Levente Knapp, Erika Krucsó, Levente Gellért, Zsolt Kis, Tamás Farkas, Ferenc Fülöp, Árpád Párdutz, János Tajti, László Vécsei & József Toldi. (2013) Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood–brain barrier permeability. Drug Design, Development and Therapy 7, pages 981-987.
Read now
Simon Akerman & Marcela Romero-Reyes. (2013) Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine. Expert Review of Neurotherapeutics 13:9, pages 1041-1059.
Read now
Martha B Ramírez Rosas, Sieneke Labruijere, Carlos M Villalón & Antoinette Maassen VanDenBrink. (2013) Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs. Expert Opinion on Pharmacotherapy 14:12, pages 1599-1610.
Read now
Svein I Bekkelund & Karl B Alstadhaug. (2011) Migraine prophylactic drugs – something new under the sun?. Expert Opinion on Investigational Drugs 20:9, pages 1201-1210.
Read now
Anna P Andreou, Oliver Summ, Annabelle R Charbit, Marcela Romero-Reyes & Peter J Goadsby. (2010) Animal models of headache: from bedside to bench and back to bedside. Expert Review of Neurotherapeutics 10:3, pages 389-411.
Read now

Articles from other publishers (52)

Horia Pleș, Ioan-Alexandru Florian, Teodora-Larisa Timis, Razvan-Adrian Covache-Busuioc, Luca-Andrei Glavan, David-Ioan Dumitrascu, Andrei Adrian Popa, Andrei Bordeianu & Alexandru Vlad Ciurea. (2023) Migraine: Advances in the Pathogenesis and Treatment. Neurology International 15:3, pages 1052-1105.
Crossref
Weihua Meng, Parminder S. Reel, Charvi Nangia, Aravind Lathika Rajendrakumar, Harry L. Hebert, Qian Guo, Mark J. Adams, Hua Zheng, Zen Haut Lu, Debashree Ray, Lesley A. Colvin, Colin N. A. Palmer, Andrew M. McIntosh & Blair H. Smith. (2022) A Meta-Analysis of the Genome-Wide Association Studies on Two Genetically Correlated Phenotypes Suggests Four New Risk Loci for Headaches. Phenomics 3:1, pages 64-76.
Crossref
Anna P. Andreou & Ana D. Pereira. 2023. Migraine Biology, Diagnosis, and Co-Morbidities. Migraine Biology, Diagnosis, and Co-Morbidities 61 69 .
Mohammad Dawood Rahimi, Pouriya Hassani, Mohammad Taghi Kheirkhah & Javad Salehi Fadardi. (2022) Effectiveness of eye movement exercise and diaphragmatic breathing with jogging in reducing migraine symptoms: A preliminary, randomized comparison trial. Brain and Behavior 13:1.
Crossref
Tarique Benbow, Felisha Teja, Afrooz Sheikhi, Fernando G. Exposto, Peter Svensson & Brian E. Cairns. (2022) Peripheral N-methyl-d-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats. Scientific Reports 12:1.
Crossref
Anna P. Andreou. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders 195 228 .
Tarique Benbow & Brian E Cairns. (2021) Dysregulation of the peripheral glutamatergic system: A key player in migraine pathogenesis?. Cephalalgia 41:11-12, pages 1249-1261.
Crossref
Anna P. Andreou, Charlotte Leese, Rosaria Greco, Chiara Demartini, Eve Corrie, Deniz Simsek, Anna Zanaboni, Ksenia Koroleva, Joseph O. Lloyd, Giorgio Lambru, Ciara Doran, Oleg Gafurov, Elizabeth Seward, Rashid Giniatullin, Cristina Tassorelli & Bazbek Davletov. (2020) Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine. Neurotherapeutics 18:1, pages 556-568.
Crossref
Anna P. Andreou & Lars Edvinsson. 2020. Neuromodulation in Headache and Facial Pain Management. Neuromodulation in Headache and Facial Pain Management 3 31 .
Sunhee Kim & In-hwan Baek. (2019) Meta-analysis on the Efficacy of Glutamate Receptor Antagonists for Acute Migraine Treatment. Korean Journal of Clinical Pharmacy 29:4, pages 247-253.
Crossref
Karl B. Alstadhaug & Anna P. Andreou. (2019) Caffeine and Primary (Migraine) Headaches—Friend or Foe?. Frontiers in Neurology 10.
Crossref
Sukhvinder Kaur, Arif Ali, Uzair Ahmad, Yaser Siahbalaei, A. K. Pandey & Balkirat Singh. (2019) Role of single nucleotide polymorphisms (SNPs) in common migraine. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 55:1.
Crossref
Anna P. Andreou & Lars Edvinsson. (2019) Mechanisms of migraine as a chronic evolutive condition. The Journal of Headache and Pain 20:1.
Crossref
Jan Hoffmann, Robin James Storer, Jeong‐Wook Park & Peter J. Goadsby. (2019) N ‐Methyl‐ d ‐aspartate receptor open‐channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats . European Journal of Neuroscience 50:5, pages 2847-2859.
Crossref
Diana Y. Wei & Rigmor H. Jensen. (2018) Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias. Neurotherapeutics 15:2, pages 346-360.
Crossref
Regina R. Berkovich, Alexey Y. Sokolov, Daniel M. Togasaki, Aida A. Yakupova, Paul-Henry Cesar & Soma Sahai-Srivastava. (2018) Dextromethorphan/Quinidine in Migraine Prophylaxis: An Open-label Observational Clinical Study. Clinical Neuropharmacology 41:2, pages 64-69.
Crossref
Jonathan Jia Yuan Ong, Diana Yi-Ting Wei & Peter J. Goadsby. (2018) Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs. Drugs 78:4, pages 411-437.
Crossref
Verneri Anttila, Maija Wessman, Mikko Kallela & Aarno Palotie. 2018. Neurogenetics, Part II. Neurogenetics, Part II 493 503 .
Gerrit L.J. Onderwater, Robin M. Van Dongen, Ronald Zielman, Gisela M. Terwindt & Michel D. Ferrari. 2018. Cerebrospinal Fluid in Neurologic Disorders. Cerebrospinal Fluid in Neurologic Disorders 267 284 .
Fabio Antonaci, Natascia Ghiotto, Shizheng Wu, Ennio Pucci & Alfredo Costa. (2016) Recent advances in migraine therapy. SpringerPlus 5:1.
Crossref
Eugene Klimov. (2015) The Role of Polymorphism of Regulatory Region of MTDH Gene (Rs1835740) in Migraine and Other Forms of Primary Headaches. Journal of Neurology & Stroke 3:4.
Crossref
Jie Fang, Xingkai An, Shuai Chen, Zhenzhen Yu, Qilin Ma & Hongli Qu. (2016) Case-control study of GRIA1 and GRIA3 gene variants in migraine. The Journal of Headache and Pain 17:1.
Crossref
A.Y. Sokolov, O.A. Lyubashina, R.R. Berkovich & S.S. Panteleev. (2015) Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats. European Journal of Pain 19:8, pages 1086-1094.
Crossref
Kelli Solly, Rebecca Klein, Michael Rudd, M. Katharine Holloway, Eric N. Johnson, Darrell Henze & Michael F.A. Finley. (2015) High-Throughput Screen of GluK1 Receptor Identifies Selective Inhibitors with a Variety of Kinetic Profiles Using Fluorescence and Electrophysiology Assays. SLAS Discovery 20:6, pages 708-719.
Crossref
Ricardo J. Carreira, Reinald Shyti, Benjamin Balluff, Walid M. Abdelmoula, Sandra H. van Heiningen, Rene J. van Zeijl, Jouke Dijkstra, Michel D. Ferrari, Else A. Tolner, Liam A. McDonnell & Arn M. J. M. van den Maagdenberg. (2015) Large-Scale Mass Spectrometry Imaging Investigation of Consequences of Cortical Spreading Depression in a Transgenic Mouse Model of Migraine. Journal of the American Society for Mass Spectrometry 26:6, pages 853-861.
Crossref
Anna P. Andreou, Philip R. Holland, Michele P. Lasalandra & Peter J. Goadsby. (2015) Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors. Pain 156:3, pages 439-450.
Crossref
Sajedeh Eftekhari, Christopher A. Salvatore, Sara Johansson, Tsing-bau Chen, Zhizhen Zeng & Lars Edvinsson. (2015) Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier. Brain Research 1600, pages 93-109.
Crossref
Anna P. Andreou & Michael L. Oshinsky. 2015. Pathophysiology of Headaches. Pathophysiology of Headaches 31 66 .
Amy R. Tso & Peter J. Goadsby. (2014) New Targets for Migraine Therapy. Current Treatment Options in Neurology 16:11.
Crossref
Kayi Chan & Antoinette MaassenVanDenBrink. (2014) Glutamate Receptor Antagonists in the Management of Migraine. Drugs 74:11, pages 1165-1176.
Crossref
Inger Jansen‐Olesen, Sarah Louise T. Christensen & Jes Olesen. 2014. In Vivo Models for Drug Discovery. In Vivo Models for Drug Discovery 231 260 .
Claudia F. Gasparini, Heidi G. Sutherland, Larisa M. Haupt & Lyn R. Griffiths. (2014) Genetic Analysis of GRIA2 and GRIA4 Genes in Migraine. Headache: The Journal of Head and Face Pain 54:2, pages 303-312.
Crossref
Bridget H. Maher, Rod A. Lea, Jordan Follett, Hannah C. Cox, Francesca Fernandez, Teresa Esposito, Fernando Gianfrancesco, Larisa M. Haupt & Lyn R. Griffiths. (2013) Association of a GRIA3 Gene Polymorphism With Migraine in an Australian Case-Control Cohort . Headache: The Journal of Head and Face Pain 53:8, pages 1245-1249.
Crossref
Peter J. Goadsby. 2013. Headache. Headache 88 99 .
Else Eising, Boukje de Vries, Michel D Ferrari, Gisela M Terwindt & Arn MJM van den Maagdenberg. (2013) Pearls and pitfalls in genetic studies of migraine. Cephalalgia 33:8, pages 614-625.
Crossref
Shazia K. AfridiNicola J. GiffinHolger KaubePeter J. Goadsby. (2013) A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology 80:7, pages 642-647.
Crossref
A.‐L. Esserlind, M. Kirchmann, A. W. Hauge, H. Le & J. Olesen. (2011) A genotype–phenotype analysis of the 8q22.1 variant in migraine with aura. European Journal of Neurology 19:4, pages 603-609.
Crossref
Jeong Wook Park, Gyoung Im Suh, Hae Eun Shin & Go Eun Park. (2012) Influence of memantine on nociceptive responses of the trigeminocervical complex after formalin injection. Cephalalgia 32:4, pages 308-316.
Crossref
Isabelle Andres-Enguix, Lijun Shang, Phillip J. Stansfeld, Julia M. Morahan, Mark S. P. Sansom, Ronald G. Lafrenière, Bishakha Roy, Lyn R. Griffiths, Guy A. Rouleau, George C. Ebers, Zameel M. Cader & Stephen J. Tucker. (2012) Functional analysis of missense variants in the TRESK (KCNK18) K+ channel. Scientific Reports 2:1.
Crossref
Markus Schürks. (2011) Genetics of migraine in the age of genome-wide association studies. The Journal of Headache and Pain 13:1, pages 1-9.
Crossref
Anne Francke Christensen, Han Le, Malene Kirchmann & Jes Olesen. (2011) Genotype–phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1. The Journal of Headache and Pain 13:1, pages 21-27.
Crossref
Anna P AndreouPeter J Goadsby. (2011) Topiramate in the treatment of migraine: A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia 31:13, pages 1343-1358.
Crossref
Simon Akerman, Philip R. Holland & Peter J. Goadsby. (2011) Diencephalic and brainstem mechanisms in migraine. Nature Reviews Neuroscience 12:10, pages 570-584.
Crossref
Lannie Ligthart, Boukje de Vries, Albert V Smith, M Arfan Ikram, Najaf Amin, Jouke-Jan Hottenga, Stephany C Koelewijn, V Mathijs Kattenberg, Marleen HM de Moor, A Cecile JW Janssens, Yurii S Aulchenko, Ben A Oostra, Eco JC de Geus, Johannes H Smit, Frans G Zitman, André G Uitterlinden, Albert Hofman, Gonneke Willemsen, Dale R Nyholt, Grant W Montgomery, Gisela M Terwindt, Vilmundur Gudnason, Brenda WJH Penninx, Monique Breteler, Michel D Ferrari, Lenore J Launer, Cornelia M van Duijn, Arn MJM van den Maagdenberg & Dorret I Boomsma. (2011) Meta-analysis of genome-wide association for migraine in six population-based European cohorts. European Journal of Human Genetics 19:8, pages 901-907.
Crossref
Daniel I Chasman, Markus Schürks, Verneri Anttila, Boukje de Vries, Ulf Schminke, Lenore J Launer, Gisela M Terwindt, Arn M J M van den Maagdenberg, Konstanze Fendrich, Henry Völzke, Florian Ernst, Lyn R Griffiths, Julie E Buring, Mikko Kallela, Tobias Freilinger, Christian Kubisch, Paul M Ridker, Aarno Palotie, Michel D Ferrari, Wolfgang Hoffmann, Robert Y L Zee & Tobias Kurth. (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nature Genetics 43:7, pages 695-698.
Crossref
Kayi Y. Chan, Steve Vermeersch, Jan de Hoon, Carlos M. Villalón & Antoinette MaassenVanDenBrink. (2011) Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects. Pharmacology & Therapeutics 129:3, pages 332-351.
Crossref
Teshamae S. Monteith & Peter J. Goadsby. (2010) Acute Migraine Therapy: New Drugs and New Approaches. Current Treatment Options in Neurology 13:1, pages 1-14.
Crossref
Tony W. Ho, Lars Edvinsson & Peter J. Goadsby. (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nature Reviews Neurology 6:10, pages 573-582.
Crossref
Amy A. GelfandHeather J. FullertonPeter J. Goadsby. (2010) Child Neurology: Migraine with aura in children. Neurology 75:5.
Crossref
Enikő Vámos, Annamária Fejes, Júlia Koch, János Tajti, Ferenc Fülöp, József Toldi, Árpád Párdutz & László Vécsei. (2010) Kynurenate Derivative Attenuates the Nitroglycerin‐Induced CamKIIα and CGRP Expression Changes. Headache: The Journal of Head and Face Pain 50:5, pages 834-843.
Crossref
Todd J. Schwedt & Stephen D. Silberstein. (2010) 14th International Headache Congress: Clinical Highlights. Headache: The Journal of Head and Face Pain 50:3, pages 509-519.
Crossref
Christian Waeber & Richard Hargreaves. 2010. Headache. Headache 789 809 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.